Inceptua Group is a global pharmaceutical services company that specializes in various business areas including clinical trial supply, services, logistics, early access programs, and worldwide distribution of unlicensed and other medicines. With over 25 years of experience in serving life science companies, Inceptua has established itself as a market leader with global operations and offices across Europe, North America, and Asia, including China. The company's last investment was a Private Equity Round investment on 16 January 2024, led by Vesey Street Capital Partners. For more information about Inceptua Group, visit www.inceptua.com.
No recent news or press coverage available for Inceptua Group.